[Diagnosis of and therapy for Alzheimer-type dementia].
Nakamura
Yu
Y
D000544:Alzheimer Disease / Q000175:diagnosis* / Q000473:pathology / Q000523:psychology / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D039721:Diagnostic and Statistical Manual of Mental Disorders; D003987:Dibenzothiazepines / Q000627:therapeutic use; D000077265:Donepezil; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D009454:Neurofibrils / Q000378:metabolism / Q000473:pathology; D010880:Piperidines / Q000627:therapeutic use; D058225:Plaque, Amyloid / Q000378:metabolism; D000069348:Quetiapine Fumarate; D012015:Reference Standards; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D016875:tau Proteins / Q000378:metabolism
D016229:Amyloid beta-Peptides; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D003987:Dibenzothiazepines; D000077265:Donepezil; D007189:Indans; D010880:Piperidines; D000069348:Quetiapine Fumarate; D017367:Selective Serotonin Reuptake Inhibitors; D016875:tau Proteins